UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 1.513

Sortiert nach

PB3 Real World Adherence, Persistence, Relapse and Multiple Sclerosis Symptoms Among Patients Treated with Oral Disease-Modifying Therapies

Value in health, 2021-06, Vol.24, p.S13-S13

2021

Volltextzugriff (PDF)

A mitochondrial component of neurodegeneration in multiple sclerosis

Neuromolecular medicine, 2003-01, Vol.3 (3), p.147-158

2003

Volltextzugriff (PDF)

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-tac

Annals of neurology, 1998-12, Vol.44 (6), p.942-947

1998

Volltextzugriff (PDF)

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis

Multiple sclerosis, 2001-02, Vol.7 (1), p.49-58

2001

Volltextzugriff (PDF)

Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice

Journal of Virology, 1989-06, Vol.63 (6), p.2813-2819

1989

Volltextzugriff (PDF)

Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral, meningitis: evaluation in murine model infections and in patients

The Journal of experimental medicine, 1988-05, Vol.167 (5), p.1743-1748

1988

Volltextzugriff (PDF)

CD45 (PTPRC) as a candidate gene in multiple sclerosis

Multiple sclerosis, 2004-12, Vol.10 (6), p.614-617

2004

Volltextzugriff (PDF)

Production of B cell stimulatory factor-2 and interferon γ in the central nervous system during viral meningitis and encephalitis: evaluation in a murine model infection and in patients

The Journal of experimental medicine, 1988-07, Vol.168 (1), p.449-453

1988

Volltextzugriff (PDF)

Functional analysis of T lymphocyte subsets in antiviral host defense

The Journal of immunology (1950), 1987-04, Vol.138 (7), p.2278

1987

Volltextzugriff (PDF)

PRM94 - Psychometric Validation Of The Fatigue Symptoms And Impacts Questionnaireâ€“Relapsing Multiple Sclerosis (Fsiq-Rmsâ„¢)

Value in health, 2015-05, Vol.18 (3), p.A26-A26

2015

Volltextzugriff (PDF)

Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b

Neurology, 2003-06, Vol.60 (11), p.1849

2003

Volltextzugriff (PDF)

A machine-assisted approach for the preparation of follow-on pharmaceutical compound libraries

Reaction chemistry & engineering, 2018-04, Vol.3 (2), p.210-215

2018

Volltextzugriff (PDF)

Mechanisms of macrophage‐mediated tumor cell killing: A comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor

International journal of cancer, 1990-10, Vol.46 (4), p.682-686

1990

Volltextzugriff (PDF)

SAFETY AND TOLERABILITY OF TERIFLUNOMIDE IN CLINICAL STUDIES

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015-11, Vol.86 (11), p.e4-e4

2015

Volltextzugriff (PDF)

HTLV-I/II Seroindeterminate Western Blot Reactivity in a Cohort of Patients with Neurological Disease

The Journal of infectious diseases, 1999-09, Vol.180 (3), p.685-694

1999

Volltextzugriff (PDF)

Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis

Multiple sclerosis and related disorders, 2018-11, Vol.26, p.260-260

2018

Volltextzugriff (PDF)

No Increase in Malignancy Risk with Cladribine Tablets in Patients with Relapsing Multiple Sclerosis

Multiple sclerosis and related disorders, 2018-11, Vol.26, p.261-261

2018

Volltextzugriff (PDF)

Pregnancy Outcomes During the Clinical Development of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety

Multiple sclerosis and related disorders, 2018-11, Vol.26, p.260-261

2018

Volltextzugriff (PDF)

Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus

Journal of Virology, 1989-11, Vol.63 (11), p.4976-4978

1989

Volltextzugriff (PDF)

Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis

Value in health, 2014-11, Vol.17 (7), p.A392-A392

2014

Volltextzugriff (PDF)

Genetics of Multiple Sclerosis: Determinants of Autoimmunity and Neurodegeneration

Autoimmunity (Chur, Switzerland), 2002, Vol.35 (4), p.225-234

2002

Volltextzugriff (PDF)

Impaired Generation of Anti‐Viral Cytotoxicity against Lymphocytic Choriomeningitis and Vaccinia Virus in Mice Treated with CD4‐Specific Monoclonal Antibody

Scandinavian journal of immunology, 1989-12, Vol.30 (6), p.679-686

1989

Volltextzugriff (PDF)

Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease

Multiple sclerosis, 2001-10, Vol.7 (5), p.313-319

2001

Volltextzugriff (PDF)

Familial Multiple Sclerosis and Other Inherited Disorders of the White Matter

The Neurologist (Baltimore, Md.), 2004-07, Vol.10 (4), p.201-215

2004

Volltextzugriff (PDF)

26 – 50 von 1.513

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.231)
Mit Volltextzugriff
(1.389)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.477)
Japanisch
(151)
Deutsch
(36)
Französisch
(5)
Russisch
(2)
Spanisch
(2)
Ungarisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

PB3 Real World Adherence, Persistence, Relapse and Multiple Sclerosis Symptoms Among Patients Treated with Oral Disease-Modifying Therapies

A mitochondrial component of neurodegeneration in multiple sclerosis

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-tac

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis

Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice

Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral, meningitis: evaluation in murine model infections and in patients

CD45 (PTPRC) as a candidate gene in multiple sclerosis

Production of B cell stimulatory factor-2 and interferon γ in the central nervous system during viral meningitis and encephalitis: evaluation in a murine model infection and in patients

Functional analysis of T lymphocyte subsets in antiviral host defense

PRM94 - Psychometric Validation Of The Fatigue Symptoms And Impacts Questionnaireâ€“Relapsing Multiple Sclerosis (Fsiq-Rmsâ„¢)

Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b

A machine-assisted approach for the preparation of follow-on pharmaceutical compound libraries

Mechanisms of macrophage‐mediated tumor cell killing: A comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor

SAFETY AND TOLERABILITY OF TERIFLUNOMIDE IN CLINICAL STUDIES

HTLV-I/II Seroindeterminate Western Blot Reactivity in a Cohort of Patients with Neurological Disease

Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis

No Increase in Malignancy Risk with Cladribine Tablets in Patients with Relapsing Multiple Sclerosis

Pregnancy Outcomes During the Clinical Development of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety

Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus

Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis

Genetics of Multiple Sclerosis: Determinants of Autoimmunity and Neurodegeneration

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

Impaired Generation of Anti‐Viral Cytotoxicity against Lymphocytic Choriomeningitis and Vaccinia Virus in Mice Treated with CD4‐Specific Monoclonal Antibody

Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease

Familial Multiple Sclerosis and Other Inherited Disorders of the White Matter

Suchergebnisse filtern